4.7 Article

A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

USP14: Structure, Function, and Target Inhibition

Feng Wang et al.

Summary: Ubiquitin-specific protease 14 (USP14) is an enzyme involved in regulating protein degradation and is associated with various diseases and cellular processes. Its activity is tightly regulated through conformational changes and phosphorylation. USP14 has gained significant interest as a therapeutic target due to its role in stabilizing disease-causing proteins and oncology targets.

FRONTIERS IN PHARMACOLOGY (2022)

Article Oncology

The two sides of Hippo pathway in cancer

Fu-Long Li et al.

Summary: The Hippo signaling pathway is an important regulatory pathway that plays a vital role in animal development and tissue homeostasis. It regulates tissue growth and organ size and is associated with various diseases, particularly cancer.

SEMINARS IN CANCER BIOLOGY (2022)

Review Biochemistry & Molecular Biology

YAP and TAZ Are Not Identical Twins

Francesca Reggiani et al.

Summary: YAP and TAZ are paralog transcriptional regulators that play roles in cell growth and differentiation by integrating mechanical, metabolic, and signaling inputs. They have both common and distinctive structural features and regulatory mechanisms, interacting with different transcriptional partners and controlling nonidentical transcriptional programs. Despite being considered functionally redundant in most literature, they have distinct or even contrasting roles in different contexts, implying significant implications for mechanistic and translational studies.

TRENDS IN BIOCHEMICAL SCIENCES (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma

Cheng Hang et al.

Summary: The study revealed that elevated expression of USP14 in pancreatic ductal adenocarcinoma is associated with poor prognosis, and USP14 may promote PDAC tumorigenesis by regulating cell proliferation, apoptosis, and metastasis.

JOURNAL OF MOLECULAR HISTOLOGY (2021)

Editorial Material Gastroenterology & Hepatology

The war against pancreatic cancer in 2020-advances on all fronts

Tejeshwar Jain et al.

Summary: In 2020, significant progress was made in three major areas of pancreatic ductal adenocarcinoma (PDAC) research: risk factors, therapeutic resistance, and tumor recurrence. The pathophysiology of obesity-mediated PDAC initiation was elucidated, novel stromal mechanisms of therapeutic resistance were unveiled, and the genetic evolution of recurrent PDAC under therapeutic pressures was tracked in human samples.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Medicine, General & Internal

Estimated Projection of US Cancer Incidence and Death to 2040

Lola Rahib et al.

Summary: This cross-sectional study projected cancer incidences and deaths in the United States up to 2040. The findings indicate significant changes in the most common cancers by 2040, with breast cancer projected to become the most common cancer and lung cancer remaining the leading cause of cancer-related death.

JAMA NETWORK OPEN (2021)

Article Oncology

Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity

Joel D. Pearson et al.

Summary: The study identifies two binary cancer classes based on the activity of YAP, providing insights into the impact of cancer heterogeneity on therapeutic response. YAP silencing is intrinsic to the cell of origin and may be acquired with lineage switching and drug resistance.

CANCER CELL (2021)

Article Oncology

Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer

Raffaela Santoro et al.

MOLECULAR CANCER THERAPEUTICS (2020)

Letter Oncology

Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models

Pei Pei Che et al.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)

Article Oncology

A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer

Michal Shreberk-Shaked et al.

CANCER RESEARCH (2020)

Article Biochemistry & Molecular Biology

OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ

Zhengkui Zhang et al.

MOLECULAR CELL (2019)

Review Biochemistry & Molecular Biology

Regulation of the Hippo signaling pathway by ubiquitin modification

Youngeun Kim et al.

BMB REPORTS (2018)

Review Oncology

YAP/TAZ at the Roots of Cancer

Francesca Zanconato et al.

CANCER CELL (2016)

Review Oncology

Current progress in immunotherapy for pancreatic cancer

Kelly Foley et al.

CANCER LETTERS (2016)

Article Cell Biology

Function of Deubiquitinating Enzyme USP14 as Oncogene in Different Types of Cancer

Ying Zhu et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)

Review Cell Biology

Regulation of TAZ in cancer

Xin Zhou et al.

PROTEIN & CELL (2016)

Article Medicine, General & Internal

Pancreatic cancer

Jorg Kleeff et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Review Biochemistry & Molecular Biology

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

Fa-Xing Yu et al.

Review Developmental Biology

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

Xaralabos Varelas

DEVELOPMENT (2014)

Article Gastroenterology & Hepatology

YAP activation is an early event and a potential therapeutic target in liver cancer development

Andrea Perra et al.

JOURNAL OF HEPATOLOGY (2014)

Article Biochemistry & Molecular Biology

Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers

Francesca Cottini et al.

NATURE MEDICINE (2014)

Review Medicine, General & Internal

Pancreatic Adenocarcinoma

David P. Ryan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Physiology

THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND

Stefano Piccolo et al.

PHYSIOLOGICAL REVIEWS (2014)

Article Multidisciplinary Sciences

Restriction of intestinal stem cell expansion and the regenerative response by YAP

Evan R. Barry et al.

NATURE (2013)

Review Oncology

The Hippo pathway and human cancer

Kieran F. Harvey et al.

NATURE REVIEWS CANCER (2013)

Article Biochemistry & Molecular Biology

The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells

Michelangelo Cordenonsi et al.

Article Cell Biology

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

Bin Zhao et al.

GENES & DEVELOPMENT (2011)

Review Cell Biology

The Hippo Signaling Pathway in Development and Cancer

Duojia Pan

DEVELOPMENTAL CELL (2010)

Article Biochemistry & Molecular Biology

The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase

Chen-Ying Liu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Enhancement of proteasome activity by a small-molecule inhibitor of USP14

Byung-Hoon Lee et al.

NATURE (2010)

Article Chemistry, Medicinal

Toward the Development of a Potent and Selective Organoruthenium Mammalian Sterile 20 Kinase Inhibitor

Ruchi Anand et al.

JOURNAL OF MEDICINAL CHEMISTRY (2009)

Article Physiology

Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ

Ryosuke Makita et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)

Article Biochemistry & Molecular Biology

Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice

Jinhua Wen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Multidisciplinary Sciences

Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1

Zakir Hossain et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65

EM Morin-Kensicki et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Biotechnology & Applied Microbiology

Protein kinases - the major drug targets of the twenty-first century?

P Cohen

NATURE REVIEWS DRUG DISCOVERY (2002)